4D Path
Tathagata Dasgupta is a seasoned professional with a diverse background in quantitative research and computational biology, holding the positions of Founder, President, and CTO at 4D Path since 2017, and Principal Collaborator at the Quantitative Criticism Laboratory since 2014. Dasgupta's expertise spans literature and culture through the lens of quantitative disciplines, particularly focusing on ancient Greek and Roman literature. Previous roles include Quantitative Researcher at Cambridge Square Capital (2016-2019), Research Consultant at HSQ Capital (2016), and Scientist at Harvard University (2008-2016), where Dasgupta specialized in systems biology and machine learning-based modeling. Additional experience includes Systems and Computational Biologist at the Cell Decision Process Center at MIT (2009-2014) and serving as a Feinberg Fellow at the Weizmann Institute of Science (2004-2007), focusing on complex systems and string theory. Tathagata Dasgupta earned a PhD in String Theory and a Master of Advanced Study in Mathematics from the University of Cambridge.
4D Path
4D Path specializes in integrating cancer diagnostics and precision medicine into a single quantitative digital platform based only on a single hematoxylin and eosin. Its patented technology is designed to be universal, with the ability to characterize underlying fundamental processes across cancer spectra in many organ systems.The company wasincorporated in 2016 and is based in Belmont, Massachusetts.